Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary : Global Atopic Dermatitis Drugs Market


4. Market Overview

4.1. Introduction

4.1.1. Definition

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Atopic Dermatitis Drugs Market Analysis and Forecasts, 2017–2027


5. Market Outlook

5.1. Disease Epidemiology

5.2. Pipeline Analysis

5.3. Recent Development


6. Global Atopic Dermatitis Drugs Market Analysis and Forecasts, by Drug Class

6.1. Introduction & Definition

6.2. Market Value Forecast by Drug Class, 2017–2027

6.2.1. Corticosteroids

6.2.2. PDE4 Inhibitors

6.2.3. Biologics

6.2.4. Skin Barrier Emollients

6.2.5. CNI Immunosuppressants

6.2.6. Others

6.3. Market Attractiveness by Drug Class


7. Global Atopic Dermatitis Drugs Market Analysis and Forecasts, by Distribution Channel

7.1. Introduction & Definition

7.2. Market Value Forecast by Distribution Channel, 2017–2027

7.2.1. Hospital Pharmacies

7.2.2. Retail Pharmacies

7.2.3. Online Pharmacies

7.3. Market Attractiveness by Distribution Channel


8. Global Atopic Dermatitis Drugs Market Analysis and Forecasts, by Region

8.1. Key Findings

8.2. Market Value Forecast by Region

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. Market Attractiveness by Country/Region


9. North America Atopic Dermatitis Drugs Market Analysis and Forecast

9.1. Introduction

9.2. Market Value Forecast by Drug Class, 2017–2027

9.2.1. Corticosteroids

9.2.2. PDE4 Inhibitors

9.2.3. Biologics

9.2.4. Skin Barrier Emollients

9.2.5. CNI Immunosuppressants

9.2.6. Others

9.3. Market Value Forecast by Distribution Channel, 2017–2027

9.3.1. Hospital Pharmacies

9.3.2. Retail Pharmacies

9.3.3. Online Pharmacies

9.4. Market Value Forecast by Country, 2017–2027

9.4.1. U.S.

9.4.2. Canada

9.5. Market Attractiveness Analysis

9.5.1. By Drug Class

9.5.2. By Distribution Channel

9.5.3. By Country


10. Europe Atopic Dermatitis Drugs Market Analysis and Forecast

10.1. Introduction

10.2. Market Value Forecast by Drug Class, 2017–2027

10.2.1. Corticosteroids

10.2.2. PDE4 Inhibitors

10.2.3. Biologics

10.2.4. Skin Barrier Emollients

10.2.5. CNI Immunosuppressants

10.2.6. Others

10.3. Market Value Forecast by Distribution Channel, 2017–2027

10.3.1. Hospital Pharmacies

10.3.2. Retail Pharmacies

10.3.3. Online Pharmacies

10.4. Market Value Forecast by Country/Sub-region, 2017–2027

10.4.1. Germany

10.4.2. U.K.

10.4.3. France

10.4.4. Spain

10.4.5. Italy

10.4.6. Rest of Europe

10.5. Market Attractiveness Analysis

10.5.1. By Drug Class

10.5.2. By Distribution Channel

10.5.3. By Country/Sub-region


11. Asia Pacific Atopic Dermatitis Drugs Market Analysis and Forecast

11.1. Introduction

11.2. Market Value Forecast by Drug Class, 2017–2027

11.2.1. Corticosteroids

11.2.2. PDE4 Inhibitors

11.2.3. Biologics

11.2.4. Skin Barrier Emollients

11.2.5. CNI Immunosuppressants

11.2.6. Others

11.3. Market Value Forecast by Distribution Channel, 2017–2027

11.3.1. Hospital Pharmacies

11.3.2. Retail Pharmacies

11.3.3. Online Pharmacies

11.4. Market Value Forecast by Country/Sub-region, 2017–2027

11.4.1. China

11.4.2. Japan

11.4.3. India

11.4.4. Australia & New Zealand

11.4.5. Rest of Asia Pacific

11.5. Market Attractiveness Analysis

11.5.1. By Drug Class

11.5.2. By Distribution Channel

11.5.3. By Country/Sub-region


12. Latin America Atopic Dermatitis Drugs Market Analysis and Forecast

12.1. Introduction

12.2. Market Value Forecast by Drug Class, 2017–2027

12.2.1. Corticosteroids

12.2.2. PDE4 Inhibitors

12.2.3. Biologics

12.2.4. Skin Barrier Emollients

12.2.5. CNI Immunosuppressants

12.2.6. Others

12.3. Market Value Forecast by Distribution Channel, 2017–2027

12.3.1. Hospital Pharmacies

12.3.2. Retail Pharmacies

12.3.3. Online Pharmacies

12.4. Market Value Forecast by Country/Sub-region, 2017–2027

12.4.1. Brazil

12.4.2. Mexico

12.4.3. Rest of Latin America

12.5. Market Attractiveness Analysis

12.5.1. By Drug Class

12.5.2. By Distribution Channel

12.5.3. By Country/Sub-region

13. Middle East & Africa Atopic Dermatitis Drugs Market Analysis and Forecast

13.1. Introduction

13.2. Market Value Forecast by Drug Class, 2017–2027

13.2.1. Corticosteroids

13.2.2. PDE4 Inhibitors

13.2.3. Biologics

13.2.4. Skin Barrier Emollients

13.2.5. CNI Immunosuppressants

13.2.6. Others

13.3. Market Value Forecast by Distribution Channel, 2017–2027

13.3.1. Hospital Pharmacies

13.3.2. Retail Pharmacies

13.3.3. Online Pharmacies

13.4. Market Value Forecast by Country/Sub-region, 2017–2027

13.4.1. GCC Countries

13.4.2. South Africa

13.4.3. Rest of Middle East & Africa

13.5. Market Attractiveness Analysis

13.5.1. By Drug Class

13.5.2. By Distribution Channel

13.5.3. By Country/Sub-region

14. Competitive Landscape

14.1. Company Profiles

14.1.1. Mylan N.V.

14.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)

14.1.1.2. Product Portfolio

14.1.1.3. SWOT Analysis

14.1.1.4. Strategic Overview

14.1.1.5. Financial Overview

14.1.2. Pfizer, Inc.

14.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)

14.1.2.2. Product Portfolio

14.1.2.3. SWOT Analysis

14.1.2.4. Strategic Overview

14.1.2.5. Financial Overview

14.1.3. LEO Pharma A/S

14.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)

14.1.3.2. Product Portfolio

14.1.3.3. SWOT Analysis

14.1.3.4. Strategic Overview

14.1.3.5. Financial Overview

14.1.4. Teva Pharmaceutical Industries Ltd

14.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)

14.1.4.2. Product Portfolio

14.1.4.3. SWOT Analysis

14.1.4.4. Strategic Overview

14.1.4.5. Financial Overview

14.1.5. Sanofi

14.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)

14.1.5.2. Product Portfolio

14.1.5.3. SWOT Analysis

14.1.5.4. Strategic Overview

14.1.5.5. Financial Overview

14.1.6. Novartis AG

14.1.6.1. Company Overview (HQ, Business Segments, Employee Strength)

14.1.6.2. Product Portfolio

14.1.6.3. SWOT Analysis

14.1.6.4. Strategic Overview

14.1.6.5. Financial Overview



List of Figures



Figure 01: Global Atopic Dermatitis Drugs Market Snapshot

Figure 02: Global Atopic Dermatitis Drugs Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027

Figure 03: Global Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, 2017–2027

Figure 04: Global Atopic Dermatitis Drugs Market Value Share (%), by Drug Class (2018)

Figure 05: Global Atopic Dermatitis Drugs Market Value Share (%), by Distribution Channel (2018)

Figure 06: Global Atopic Dermatitis Drugs Market Value Share (%), by Region (2018)

Figure 07: Global Atopic Dermatitis Drugs Market Value Share Analysis, by Drug Class, 2018 and 2027

Figure 08: Global Atopic Dermatitis Drugs Market Attractiveness, by Drug Class, 2019–2027

Figure 09: Global Atopic Dermatitis Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Corticosteroids, 2017–2027

Figure 10: Global Atopic Dermatitis Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by PDE4 Inhibitors, 2017–2027

Figure 11: Global Atopic Dermatitis Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Biologics, 2017–2027

Figure 12: Global Atopic Dermatitis Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Skin Barrier Emollients, 2017–2027

Figure 13: Global Atopic Dermatitis Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by CNI Immunosuppressants, 2017–2027

Figure 14: Global Atopic Dermatitis Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2027

Figure 15: Global Atopic Dermatitis Drugs Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 16: Global Atopic Dermatitis Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacies, 2017–2027

Figure 17: Global Atopic Dermatitis Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail Pharmacies, 2017–2027

Figure 18: Global Atopic Dermatitis Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online Pharmacies, 2017–2027

Figure 19: Global Atopic Dermatitis Drugs Market Attractiveness, by Distribution Channel, 2019–2027

Figure 20: Global Atopic Dermatitis Drugs Market Value Share Analysis, by Region, 2018 and 2027

Figure 21: Global Atopic Dermatitis Drugs Market Attractiveness, by Region, 2019–2027

Figure 22: North America Atopic Dermatitis Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 23: North America Atopic Dermatitis Drugs Market Value Share (%), by Country, 2018 and 2027

Figure 24: North America Atopic Dermatitis Drugs Market Attractiveness, by Country, 2019–2027

Figure 25: North America Atopic Dermatitis Drugs Market Value Share (%), by Drug Class, 2018 and 2027

Figure 26: North America Atopic Dermatitis Drugs Market Attractiveness, by Drug Class, 2019–2027

Figure 27: North America Atopic Dermatitis Drugs Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 28: North America Atopic Dermatitis Drugs Market Attractiveness, by Distribution Channel, 2019–2027

Figure 29: Europe Atopic Dermatitis Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 30: Europe Atopic Dermatitis Drugs Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 31: Europe Atopic Dermatitis Drugs Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 32: Europe Atopic Dermatitis Drugs Market Value Share (%), by Drug Class, 2018 and 2027

Figure 33: Europe Atopic Dermatitis Drugs Market Attractiveness, by Drug Class, 2019–2027

Figure 34: Europe Atopic Dermatitis Drugs Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 35: Europe Atopic Dermatitis Drugs Market Attractiveness, by Distribution Channel, 2019–2027

Figure 36: Asia Pacific Atopic Dermatitis Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 37: Asia Pacific Atopic Dermatitis Drugs Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 38: Asia Pacific Atopic Dermatitis Drugs Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 39: Asia Pacific Atopic Dermatitis Drugs Market Value Share (%), by Drug Class, 2018 and 2027

Figure 40: Asia Pacific Atopic Dermatitis Drugs Market Attractiveness, by Drug Class, 2019–2027

Figure 41: Asia Pacific Atopic Dermatitis Drugs Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 42: Asia Pacific Atopic Dermatitis Drugs Market Attractiveness, by Distribution Channel, 2019–2027

Figure 43: Latin America Atopic Dermatitis Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026

Figure 44: Latin America Atopic Dermatitis Drugs Market Value Share (%), by Country/Sub-region 2018 and 2027

Figure 45: Latin America Atopic Dermatitis Drugs Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 46: Latin America Atopic Dermatitis Drugs Market Value Share (%), by Drug Class, 2018 and 2027

Figure 47: Latin America Atopic Dermatitis Drugs Market Attractiveness, by Drug Class, 2019–2027

Figure 48: Latin America Atopic Dermatitis Drugs Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 49: Latin America Atopic Dermatitis Drugs Market Attractiveness, by Distribution Channel, 2019–2027

Figure 50: Middle East & Africa Atopic Dermatitis Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 51: Middle East & Africa Atopic Dermatitis Drugs Market Value Share (%), by Country/Sub-region 2018 and 2027

Figure 52: Middle East & Africa Atopic Dermatitis Drugs Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 53: Middle East & Africa Atopic Dermatitis Drugs Market Value Share (%), by Drug Class, 2018 and 2027

Figure 54: Middle East & Africa Atopic Dermatitis Drugs Market Attractiveness, by Drug Class, 2019–2027

Figure 55: Middle East & Africa Atopic Dermatitis Drugs Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 56: Middle East & Africa Atopic Dermatitis Drugs Market Attractiveness, by Distribution Channel, 2019–2027

Figure 57: Mylan N.V. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2018

Figure 58: Mylan N.V. R&D Expenses (US$ Mn), 2016–2018

Figure 59: Mylan N.V. Breakdown of Net Sales (%), by Region, 2018

Figure 60: Mylan N.V. Breakdown of Net Sales (%), by Business Segment, 2018

Figure 61: Pfizer, Inc. Breakdown of Net Sales, by Region, 2018

Figure 62: Pfizer, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2018

Figure 63: Pfizer, Inc. R&D Expenses (US$ Mn), 2016–2018

Figure 64: LEO Pharma A/S Breakdown of Net Sales, by Region (2018)

Figure 65: LEO Pharma A/S Breakdown of Net Sales, by Therapeutic Area (2018)

Figure 66: LEO Pharma A/S Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2018

Figure 67: LEO Pharma A/S R&D Expenses (US$ Mn), 2016–2018

Figure 68: Sanofi Revenue (US$ Bn), 2015–2018

Figure 69: Sanofi Regional Sales Breakdown (%), 2018

Figure 70: Novartis AG Breakdown of Net Sales, by Region, 2018

Figure 71: Novartis AG Breakdown of Net Sales, by Business Segment, 2018

Figure 72: Novartis AG Revenue (US$ Bn) and Y-o-Y Growth (%), 2015–2018

Figure 73: Novartis AG R&D Expenses (US$ Mn), 2016–2018

Figure 74: Teva Pharmaceutical Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2018

Figure 75: Teva Pharmaceutical R&D Expenses (US$ Mn), 2016–2018

Figure 76: Teva Pharmaceutical Breakdown of Net Sales, by Region, 2018

Figure 77: Teva Pharmaceutical Breakdown of Net Sales, (Overall Company Level), 2018


List of Tables


List of Tables

Table 01: Global Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 02: Global Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 03: Global Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 04: North America Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 05: North America Atopic Dermatitis Drugs Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 06: North America Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 07: Europe Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 08: Europe Atopic Dermatitis Drugs Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 09: Europe Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 10: Asia Pacific Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 11: Asia Pacific Atopic Dermatitis Drugs Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 12: Asia Pacific Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 13: Latin America Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 14: Latin America Atopic Dermatitis Drugs Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 15: Latin America Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 16: Middle East & Africa Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 17: Middle East & Africa Atopic Dermatitis Drugs Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 18: Middle East & Africa Atopic Dermatitis Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027